Furthermore, the newly available oral semaglutidethe first oral formulation of GLP-1 RA for the treatment of T2D [98]has shown efficacy, safety and tolerability in a number of studies [35, 44,45,46,47,48,49,50,51]
Using supplements promising weight loss may trigger disordered eating patterns or unhealthy relationships with food and body image
A study of Chinese patients with type 2 diabetes showed good tolerability with low discontinuation rates due to side effects
In conclusion, this first report demonstrated a successful desensitization protocol to exenatide in patients with isolated immediate skin reaction and local reactions and indicated the importance of desensitization in patients who do not have alternative therapies